Ledger.Open graph →
SEC Form D · filed December 17, 2019

Protego Biopharma

Offering
$1.0M
Sold
$1.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SAN DIEGO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

Edward W. Hurwitz · Brisbane, CADirectorJeffery W. Kelly · La Jolla, CAPromoterXin Jiang · San diego, CAExecRichard Labaudiniere · Charleston, SCDirectorXin Jiang · San diego, CAExecEdward W. Hurwitz · Brisbane, CADirectorJeffery W. Kelly · La Jolla, CAPromoterRichard Labaudiniere · Charleston, SCDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗

Protego Biopharma — SEC Form D filing (2019) | Ledger